References

  1. Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, Vose J, Armitage JO, Liang R. International Peripheral T-CellLymphoma Project: clinical differences between nasal and extranasalnatural killer/Tcell lymphoma: A study of 136 cases from the international peripheral T-cell lymphoma project. Blood. 2009 Apr 23;113(17):3931-7. PubMed | Google Scholar

  2. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations - Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 1998 Jul;9(7):717-20. PubMed | Google Scholar

  3. Chuang SS, Lin CN, Li CY. Malignant lymphoma in southern Taiwan according to the revised European American classification of lymphoid neoplasms. Cancer. 2000 Oct 1;89(7):1586-92. PubMed | Google Scholar

  4. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int. 2000 Sep;50(9):696-702. PubMed | Google Scholar

  5. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008 May;9(5):503-10. PubMed | Google Scholar

  6. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe E. WHO classification of Tumors of Haematopoietic and Lymphoid Tissues. Blood. 2011;117(19):5019-5032. PubMed | Google Scholar

  7. Bagdi E, Diss TC, Munson P, Isaacson PG. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood. 1999;94:260-264. PubMed | Google Scholar

  8. Arnulf B, Copie-Bergman C, Delfau-Larue MH, Lavergne-Slove A, Bosq J, Wechsler J, Wassef M, Matuchansky C, Epardeau B, Stern M, Bagot M, Reyes F, Gaulard P. Nonhepatosplenic gamma-delta Tcell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood. 1998;91:1723-1731. PubMed | Google Scholar

  9. Chott A, Haedicke W, Mosberger I, Födinger M, Winkler K, Mannhalter C, Müller-Hermelink HK. Most CD56+ intestinal lymphomas are CD8 + CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol. 1998 Nov;153(5):1483-90. PubMed | Google Scholar

  10. Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: A clinicopathologic analysis of455 patients with special reference to its time trends. Cancer. 2003 May 15;97(10):2462-73. PubMed | Google Scholar

  11. Chott A, Dragoscic B, Radaszkiewicz T. Peripheral T-cell lymphoma of the intestine. Am J Pathol. 1992 Dec;141(6):1361-71. PubMed | Google Scholar

  12. Feller AC, Diebold J. Extranodal lymphoma. In: Feller AC, Diebold J, eds. Histopathology of Nodal and Extranodal Non-Hodgkin‘s Lymphomas. Berlin; Germany: Springer; 2004:205-213. Google Scholar

  13. Zhang WY, Li GD, Liu WP, Ouyang Q, Ren XC, Li FY, Xu H. Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection. Chin Med J (Engl). 2005; 118: 1542-1548. PubMed | Google Scholar

  14. Tung CL, Hsieh PP, Chang JH, Chang JH, Chen RS, Chen YJ, Wang JS. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: Natural killer-like cytotoxic T cell and true natural killer cell. Human Pathology. 2008 Jul;39(7):1018-25. PubMed | Google Scholar

  15. Shumei Z, Qin O, Gandi L, Hui X, Mingde J, Dejun C, Linyun X, Jinnan L. Primary intestinal NK/T Cell Lymphoma: a clinicopathologic study of 25 chinese cases. Arch Iran Med. 2012; 15(1):36–42. PubMed | Google Scholar

  16. Takenaka K, Shinagawa K, Maeda Y, Makita M, Kozuka T, Ashiba A, Yamamoto K, Fujii N, Nawa Y, Hiramatsu Y, Sunami K, Ishimaru F, Yoshimo T, Kiura K, Harada M. High- dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal-type CD56+ natural killer cell lymphoma. Leuk Lymphoma. 2001 Nov-Dec;42(6):1297-303. PubMed | Google Scholar

  17. Ko YH, Cho EY, Kim JE, Lee SS, Huh JR, Chang HK, Yang WI, Kim CW, Kim SW, Ree HJ. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status. Histopathology. 2004 May;44(5):480-9. PubMed | Google Scholar

  18. Yang QP, Zhang WY, Yu JB, Zhao S, Xu H, Wang WY, Bi CF, Zuo Z, Wang XQ, Huang J, Dai L, Liu WP. Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol. 2011 Aug 22;6:77. PubMed | Google Scholar

  19. Kanemitsu N, Isobe Y, Masuda A, Momose S, Higashi M, Tamaru J, Sugimoto K, Komatsu N. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell lymphoma, nasal type (ENKL):differences in biologic and clinical behaviors of LMP1-positive and –negative ENKL. Clin Cancer Res. 2012 Apr 15;18(8):2164-72. PubMed | Google Scholar

  20. Jaccard A, Gachard N, Marin B, Rogez S, Audrain M, Suarez F, Tilly H, Morschhauser F, Thieblemont C, Ysebaert L, Devidas A, Petit B, de Leval L, Gaulard P, Feuillard J, Bordessoule D, Hermine O. GELA and GOELAMS Intergroup - Efficacy of L- asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood. 2011 Feb 10;117(6):1834-9. PubMed | Google Scholar